Medtronic has completed its acquisition of Scientia Vascular, a Salt Lake City-based medical device firm, in a transaction valued at $550 million. The deal, which includes potential post-acquisition earn-outs and milestone payments, bolsters Medtronic's neurovascular portfolio by integrating Scientia's specialized access technologies. Scientia is recognized for its high-performance guidewires and catheters designed to navigate the complex anatomy of the cerebral vasculature. Medtronic expects the acquisition to be minimally dilutive to its adjusted earnings per share in fiscal year 2027, with anticipated accretion thereafter.
Medtronic PLCMedtronic completes $550M acquisition of Scientia Vascular, expected to be accretive after FY2027.
Scientia Vascular is acquired by Medtronic for $550M, providing an exit for its owners.